nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA1D—forebrain—narcolepsy	0.00421	0.113	CbGeAlD
Phentolamine—NISCH—medulla oblongata—narcolepsy	0.00364	0.0977	CbGeAlD
Phentolamine—NISCH—midbrain—narcolepsy	0.00333	0.0893	CbGeAlD
Phentolamine—ADRA1A—brainstem—narcolepsy	0.0025	0.0672	CbGeAlD
Phentolamine—ADRA1A—forebrain—narcolepsy	0.00242	0.0648	CbGeAlD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00216	0.00224	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00216	0.00224	CbGpPWpGaD
Phentolamine—SIGMAR1—medulla oblongata—narcolepsy	0.00212	0.0568	CbGeAlD
Phentolamine—NISCH—brain—narcolepsy	0.00209	0.0561	CbGeAlD
Phentolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00209	0.00217	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00206	0.00214	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00206	0.00214	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00205	0.00213	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—TRH—narcolepsy	0.00205	0.00213	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00204	0.00212	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00199	0.00207	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00199	0.00207	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00197	0.00205	CbGpPWpGaD
Phentolamine—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00197	0.00205	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00196	0.00203	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00196	0.00203	CbGpPWpGaD
Phentolamine—SIGMAR1—midbrain—narcolepsy	0.00194	0.052	CbGeAlD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00193	0.002	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—TRH—narcolepsy	0.00192	0.00199	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00189	0.00196	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00187	0.00195	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00187	0.00195	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00186	0.00194	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00186	0.00194	CbGpPWpGaD
Phentolamine—ADRA2A—forebrain—narcolepsy	0.00184	0.0493	CbGeAlD
Phentolamine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00183	0.0019	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00183	0.0019	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00183	0.0019	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00181	0.00188	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0018	0.00187	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0018	0.00187	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—P2RY11—narcolepsy	0.0018	0.00187	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—HRH3—narcolepsy	0.0018	0.00187	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00179	0.00186	CbGpPWpGaD
Phentolamine—ADRA1B—brain—narcolepsy	0.00179	0.0479	CbGeAlD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00176	0.00183	CbGpPWpGaD
Phentolamine—ADRA1D—brain—narcolepsy	0.00175	0.0468	CbGeAlD
Phentolamine—ADRA2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00174	0.00181	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00174	0.00181	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00171	0.00178	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00171	0.00178	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.0017	0.00176	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00169	0.00176	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00169	0.00176	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—P2RY11—narcolepsy	0.00168	0.00175	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—HRH3—narcolepsy	0.00168	0.00175	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00168	0.00174	CbGpPWpGaD
Phentolamine—ADRA2C—medulla oblongata—narcolepsy	0.00166	0.0446	CbGeAlD
Phentolamine—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00165	0.00172	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00165	0.00172	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00165	0.00172	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00165	0.00172	CbGpPWpGaD
Phentolamine—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00164	0.0017	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—P2RY11—narcolepsy	0.00163	0.0017	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0016	0.00166	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0016	0.00166	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00158	0.00164	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00158	0.00164	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00156	0.00162	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00162	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00162	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00154	0.0016	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00153	0.00159	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.00153	0.00159	CbGpPWpGaD
Phentolamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00152	0.00158	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00152	0.00158	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00152	0.00158	CbGpPWpGaD
Phentolamine—ADRA2C—midbrain—narcolepsy	0.00152	0.0408	CbGeAlD
Phentolamine—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00151	0.00157	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.0015	0.00156	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—TAC1—narcolepsy	0.00149	0.00155	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—NPS—narcolepsy	0.00149	0.00155	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00149	0.00154	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00149	0.00154	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00147	0.00153	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00147	0.00153	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00146	0.00152	CbGpPWpGaD
Phentolamine—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00145	0.00151	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.00143	0.00148	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00141	0.00147	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00141	0.00147	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00146	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00145	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00145	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HCRT—narcolepsy	0.00139	0.00144	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00138	0.00144	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00138	0.00144	CbGpPWpGaD
Phentolamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00137	0.00143	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00137	0.00143	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00137	0.00142	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00137	0.00142	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00137	0.00142	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00137	0.00142	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PENK—narcolepsy	0.00136	0.00142	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00133	0.00139	CbGpPWpGaD
Phentolamine—ADRA2A—medulla oblongata—narcolepsy	0.00133	0.0356	CbGeAlD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0013	0.00136	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0013	0.00135	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.0013	0.00135	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00128	0.00133	CbGpPWpGaD
Phentolamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00133	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.00128	0.00133	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.00128	0.00133	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00133	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00132	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CHKB—narcolepsy	0.00127	0.00132	CbGpPWpGaD
Phentolamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00126	0.00131	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00125	0.0013	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00125	0.0013	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00124	0.00129	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PENK—narcolepsy	0.00124	0.00129	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00122	0.00126	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00122	0.00126	CbGpPWpGaD
Phentolamine—SIGMAR1—brain—narcolepsy	0.00122	0.0326	CbGeAlD
Phentolamine—ADRA2A—midbrain—narcolepsy	0.00121	0.0326	CbGeAlD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00118	0.00122	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00117	0.00121	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00116	0.00121	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—TRH—narcolepsy	0.00116	0.0012	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.00116	0.0012	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00118	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00113	0.00118	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.00113	0.00118	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.00113	0.00118	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00113	0.00117	CbGpPWpGaD
Phentolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00112	0.00117	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00111	0.00116	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00111	0.00115	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00111	0.00115	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.00114	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00113	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00108	0.00112	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00107	0.00111	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00111	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.00105	0.0011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TRH—narcolepsy	0.00105	0.00109	CbGpPWpGaD
Phentolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00104	0.00108	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.00103	0.00107	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CHKB—narcolepsy	0.00103	0.00107	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00102	0.00106	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HRH3—narcolepsy	0.00102	0.00106	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00101	0.00105	CbGpPWpGaD
Phentolamine—ADRA1A—brain—narcolepsy	0.001	0.0269	CbGeAlD
Phentolamine—ADRA2B—Signaling Pathways—HCRTR1—narcolepsy	0.001	0.00104	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HCRTR2—narcolepsy	0.001	0.00104	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.000994	0.00103	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.000984	0.00102	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.000968	0.00101	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—P2RY11—narcolepsy	0.000965	0.001	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000962	0.000999	CbGpPWpGaD
Phentolamine—ADRA2C—brain—narcolepsy	0.000956	0.0256	CbGeAlD
Phentolamine—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.00095	0.000987	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.000947	0.000984	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.00094	0.000976	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.000935	0.000971	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.000934	0.00097	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.000934	0.00097	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.000933	0.000969	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.000933	0.000969	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HRH3—narcolepsy	0.000923	0.000959	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.000919	0.000955	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.000919	0.000955	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.000909	0.000944	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.000902	0.000937	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—HTR2A—narcolepsy	0.000897	0.000932	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000894	0.000928	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.000888	0.000922	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.00088	0.000914	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.000863	0.000896	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CPT1B—narcolepsy	0.000862	0.000896	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00086	0.000893	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.000849	0.000882	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.000848	0.00088	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.000848	0.00088	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—TAC1—narcolepsy	0.000843	0.000875	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—NPS—narcolepsy	0.000843	0.000875	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.000838	0.00087	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00083	0.000863	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.000825	0.000857	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HCRT—narcolepsy	0.000821	0.000853	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000816	0.000848	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000816	0.000848	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00081	0.000842	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000799	0.00083	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.000788	0.000819	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	0.000787	0.000818	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	0.000787	0.000818	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.000775	0.000805	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.000775	0.000805	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000772	0.000801	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HCRT—narcolepsy	0.000767	0.000797	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TAC1—narcolepsy	0.000765	0.000795	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—NPS—narcolepsy	0.000765	0.000795	CbGpPWpGaD
Phentolamine—ADRA2A—brain—narcolepsy	0.000763	0.0205	CbGeAlD
Phentolamine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000758	0.000788	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000758	0.000788	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.000755	0.000784	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000754	0.000783	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000733	0.000761	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.000732	0.000761	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PENK—narcolepsy	0.000732	0.00076	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	0.000715	0.000742	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—NPS—narcolepsy	0.000715	0.000742	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.000703	0.000731	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.000703	0.000731	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000701	0.000728	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CPT1B—narcolepsy	0.0007	0.000727	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000689	0.000716	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000688	0.000715	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000688	0.000715	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PENK—narcolepsy	0.000683	0.00071	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000681	0.000707	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000673	0.000699	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00067	0.000696	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000639	0.000664	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000639	0.000664	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000625	0.000649	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000625	0.000649	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000623	0.000647	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TRH—narcolepsy	0.000622	0.000646	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000604	0.000628	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000597	0.000621	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TRH—narcolepsy	0.000581	0.000604	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000581	0.000603	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000581	0.000603	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000572	0.000594	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000561	0.000583	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000555	0.000577	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HRH3—narcolepsy	0.000546	0.000567	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.00051	0.00053	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HRH3—narcolepsy	0.00051	0.000529	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000508	0.000528	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000507	0.000527	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.000502	0.000521	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000501	0.00052	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000501	0.00052	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000474	0.000492	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000472	0.00049	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000466	0.000484	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HTR2A—narcolepsy	0.00046	0.000478	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NPS—narcolepsy	0.000452	0.00047	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TAC1—narcolepsy	0.000452	0.00047	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000445	0.000463	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	0.00043	0.000447	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000423	0.00044	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TAC1—narcolepsy	0.000422	0.000439	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NPS—narcolepsy	0.000422	0.000439	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000416	0.000432	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000416	0.000432	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000414	0.00043	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000414	0.00043	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000385	0.0004	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000376	0.00039	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000369	0.000383	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000369	0.000383	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000349	0.000363	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000343	0.000356	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000343	0.000356	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000301	0.000313	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR2A—narcolepsy	0.000272	0.000282	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	0.000254	0.000264	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.00025	0.00026	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000222	0.000231	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000206	0.000214	CbGpPWpGaD
